Quantum Biopharma Provides Corporate Update
Quantum BioPharma granted 572,500 stock options to directors, officers, and consultants, exercisable at C$4.80 for a five-year term expiring in August 2031.
Key figures
- Options granted
- 572500
- Exercise price cad
- C$4.80
- Unbuzzd royalty cap
- $250 million
- Unbuzzd ownership percent
- 19.48%
- Options performance vested
- 400000
- Options vested immediately
- 172500
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.